| |
Genta :
Tesetaxel Receives FDA Designation as an Orphan Drug for Treatment of Advanced Melanoma |
|
| |
NuVision :
NuVision Appoints Market Share, Inc. Pacific Northwest Representative |
|
| |
NuVision :
NuVision Appoints Northeast U.S. Rep |
|
| |
XTL Bio :
XTL Biopharmaceuticals Announces Completion of the Bicifadine Phase 2b Study |
|
| |
Genta :
Genta Updates Progress of its Phase 3 Trial of Genasense® |
|
| |
Javelin Pharmaceutical :
Javelin Pharmaceuticals Completes Patient Enrollment for Second of two Pivotal Phase 3 Studies of Dyloject™ |
|
| |
Genta :
Completion of Accrual to Genasense® AGENDA Trial in Advanced Melanoma Is Approved |
|
| |
NuVision :
NuVision Announces New Lines At CEDIA 2008 Expo |
|
| |
Promia :
Nexant-Promia Partnership Provides Ferc Compliant Security For Energy Companies |
|
| |
ET Water :
Letting The Weather Control The Water |
|
| |
Genta :
FDA Accepts Genta’s NDA Amendment as Complete Response |
|
| |
XTL Bio :
XTL Biopharmaceuticals Announces First Half 2008 Financial Results |
|
| |
Javelin Pharmaceutical :
Javelin Pharmaceuticals Reports Second Quarter 2008 Financial Results |
|
| |
XTL Bio :
XTL to Receive Additional $2 Million in Cash |
|
| |
Javelin Pharmaceutical :
Javelin and Baxter Healthcare Expand Commercial Supply Relationship for Dyloject |
|
| |
ET Water :
Global Change Feature Grabs Commercial Landscapers Attention |
|
| |
ET Water :
Smart irrigation system controllers take the guesswork out of watering the garden |
|
| |
XTL Bio :
XTLB Announces Completion of Patient Randomization Into the Bicifadine Phase 2b Trial |
|
| |
Genta :
FDA Lifts Clinical Hold on Genta’s Tesetaxel, a Leading Oral Taxane |
|
| |
Javelin Pharmaceutical :
Javelin Pharmaceuticals Enrolls First Patient in Pivotal Trial for PMI-150 |
|
| |
Genta :
Genta Updates Progress of its Phase 3 Trial of Genasense® in Patients |
|
| |
ET Water :
ET Water Selected Winner Of The San Francisco Business Times Green Product Award |
|
| |
Pear Tree Pharmaceutical :
Akela Pharma Awarded Development Contract from Pear Tree |
|
| |
Javelin Pharmaceutical :
Javelin Pharmaceuticals' Founder and President Transitions to Executive Director |
|
| |
Javelin Pharmaceutical :
Javelin Pharmaceuticals Announces New Patent Covering PMI-150 |
|
| |
NuVision :
Home Theater Magazine Reviews NuVision Monitor |
|
| |
XTL Bio :
XTL Biopharmaceuticals Announces Appointment of Laurence N. Charney to Board of Directors |
|
| |
Dekker Foundation :
Bachmann-Strauss Dystonia and Parkinson Foundation Honors Dekker Foundation |
|
| |
Promia :
U.S. Navy Reorders Promia Products And Services |
|
| |
XTL Bio :
XTL Biopharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference |
|
| |
Javelin Pharmaceutical :
Javelin Pharmaceuticals Reports First Quarter 2008 Results |
|
| |
Javelin Pharmaceutical :
Javelin Pharmaceuticals to Announce First Quarter 2008 Financial Results |
|
| |
Javelin Pharmaceutical :
Javelin Pharmaceuticals, Inc. to Raise $27.6 Million through Registered Direct Offering |
|
| |
NuVision :
UltimateAVmag.com reviews NuVision NVU52DCM TV |
|
| |
Javelin Pharmaceutical :
Javelin Pharmaceuticals Appoints John C. Taylor as Vice President of Business Development |
|
| |
Promia :
Promia Raven in the Worlds Best Technology Showcase |
|
| |
Javelin Pharmaceutical :
Javelin CEO to Present at Fortis Biotechnology Conference in London England |
|
| |
XTL Bio :
XTL Biopharmaceuticals Announces Financial Results for the Year Ended December |
|
| |
XTL Bio :
XTL Biopharmaceuticals Signs $108 Million Deal Licensing of Hepatitis C Program to Presidio |
|
| |
XTL Bio :
Presidio Pharmaceuticals Obtains Rights to XTL Biopharmaceuticals Hepatitis C Virus Program |
|
| |
Javelin Pharmaceutical :
Javelin Pharmaceuticals CEO to Present at Cowen & Company's 28th Annual Health Care Conference |
|
| |
Javelin Pharmaceutical :
Javelin Pharmaceuticals' Dyloject Accepted by Scottish Medicines Consortium (SMC) |
|
| |
Pear Tree Pharmaceutical :
Pear Tree aims for FDA OK of hormone treatment |
|
| |
Javelin Pharmaceutical :
Javelin Pharmaceuticals Reports Results for the Year Ended 2007 |
|
| |
Promia :
RTI Awarded U.S. Air Force Contract For Advanced Security Protection |
|
| |
Javelin Pharmaceutical :
Javelin Pharmaceuticals Board Appoints Industry Veteran Martin Driscoll as Chief Executive Officer |
|
| |
Promia :
Growth of Anti-Botnet Startups Points to AV Deficiencies |
|
| |
XTL Bio :
Punk Ziegel & Company Reiterates Thier Buy Rating and Price Target of $7.00 |
|
| |
Encysive :
Pfizer to acquire Encysive in $195 million deal |
|
| |
Encysive :
Pfizer to Acquire Encysive Pharmaceuticals |
|
| |
Summit Communications, LLC :
Summit Licenses Turkish Publishing Rights for BMT Monograph |
|
| |
ET Water :
Water Agencies Providing Rebates for ETwater Smart Controllers |
|
| |
XTL Bio :
XTL Biopharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference |
|
| |
Encysive :
Encysive Pharmaceuticals Launches THELIN (Sitaxentan Sodium) in Sweden |
|
| |
ET Water :
ET Water Featured In San Diego Building Industy Association Article On Green Products |
|
| |
NuVision :
NuVision Now Shipping 42, 47, and 52-inch Lucidium Series 1080p Deep Black LCD Panels |
|
| |
Summit Communications, LLC :
Summit Publishes Breakthrough Hypertension Monograph |
|
| |
Encysive :
Encysive Pharmaceuticals Launches THELIN (sitaxentan sodium) in Belgium and Luxembourg |
|
| |
Dekker Foundation :
Engineering Excellence Awards, Dekker Foundation Scholarship Bestowed |
|
| |
Promia :
Local Banks Beef Up Security |
|
| |
Dekker Foundation :
Dekker Foundation Supports Boys and Girls Harbor |
|
| |
XTL Bio :
XTL Biopharmaceuticals to Present at the 26th Annual JPMorgan Healthcare Conference |
|
| |
ET Water :
C.I.A. Services Reports ET Water Delivers $20,000 Savings at Houson, Texas Site |
|
| |
Promia :
U.S. Navy Buys New Promia Raven Appliances |
|
| |
Dekker Foundation :
Cynthia K. Larive, Univ. of California Riverside Recipient of Award Sponsored by Dekker Foundation |
|
| |
Promia :
Intelligent Agent Security Module (IASM) |
|
| |
Dekker Foundation :
Bachmann Strauss Dystonia & Parkinson's 15th Annual Golf Invitational Raises Over $1.7 Million |
|
| |
|
